Examinations for women with high risk pregnancy, early diagnosis of fetal abnormalities, and automatic measurement solutions in ultrasound for delivery—quality healthcare solutions enabled by Samsung Medison—have been acknowledged and noted in the medical profession.

The devices will be showcased on an online platform prepared for the virtual event, which will feature webinars, virtual exhibitions and chat tools. Samsung Medison will display its new HERA series of ultrasound devices (HERA W10, HERA I10, HERA W9) featuring its new advanced technologies and solutions. The various Intelligent Assist solutions, elaborating on the details will be presented in a video format.

The solutions which expand across the full spectrum of diagnostic functions and capabilities include the following:

• BiometryAssist – Measures the fetal growth index quickly and confidently with the view that has been acquired semi-automatically.
• HeartAssist¹ – Helps to measure and provide a suitable guideline view for an early finding of congenital heart abnormalities for the fetus before it is born, utilizing deep learning.
• LaborAssist – Allows easy discovery of changes over the measured time, and provides demo video and animation images for clear explanation and communication of the delivery process to the mothers.

BiometryAssist and LaborAssist are expected to simplify the user’s workflow by not only reducing simple repetitive manual tasks, but also increasing measurement accuracy and providing consistent measurements.

These two features have been developed by incorporating the Intel Distribution of the OpenVINO toolkit into Samsung’s diagnostic algorithm. By using the OpenVINO toolkit, powered by Intel processors, data processing moves at a speed 4.7 times faster than equipment without the OpenVINO enhancements.²

“Our Intelligent Assist solutions enhance patient comfort and clinician’s convenience, reduce scan time, improve diagnosis accuracy, and increase system throughput. Samsung will continue to develop the next-generation ultrasound solutions in collaboration with Intel for the ongoing development of Intelligent Assist solutions,” announced Won-Chul Bang, Vice President of Health & Medical Equipment Business, Samsung Electronics and Samsung Medison.

The event also includes three rounds of webinars, during which world prominent OB/GYN specialists will share the clinical results of various diagnostic tools, including MV-Flow, LumiFlow and CrystalVue, which are available in the HERA series.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Intel, the Intel logo, and OpenVINO are trademarks of Intel Corporation or its subsidiaries.

The screen that automatically recognizes and annotates the heart on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

The screen that automatically recognizes the heart and displays measured values on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

¹ 510(k) pending at FDA

² Source: Internal Samsung testing.
System configuration: Intel Core i3-4100Q CPU @ 2.4 GHz, 8 GB memory; OS: 64-bit Windows 10.
Inference time without OpenVINO enhancements was 480 milliseconds. Inference time with OpenVINO enhancements was 85 milliseconds.

Samsung showcases premium new ultrasound systems ‘HERA W10’ and ‘HERA I10’ at ISUOG World Congress 2018

HERA is a new premium platform which stands for Hyper-aperture Enhanced Reconstruction Architecture, incorporating Samsung’s new Crystal Architecture to provide advanced technology and capabilities with a new level of image quality. Samsung’s new platform combines Crystal Architecture with an advanced transducer technology called S-Vue. It allows an 11-fold increase in processing power and 10 times the data transfer speed of Samsung’s previous system. It is expected to facilitate the examination of high-risk pregnancies and early diagnosis of abnormal fetus conditions.

“Samsung is proud to introduce a new premium ultrasound system HERA W10 and a form factor innovation ultrasound HERA I10, as well as solutions that greatly improve the efficiency of hospitals,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to provide the best solutions possible and bring meaningful changes in the healthcare industry.”

New features for Samsung’s HERA W10 ultrasound system offer clinicians an optimized workflow and more information to overcome challenges, including:

Outstanding Image Quality

• Crystal Architecture – Offers a superior image with single crystal probe technology S-Vue, a new beamforming technology CrystalBeam and an advanced post-processing engine CrystalLive.
• ShadowHDR – Provides a shadow suppressed image, especially applicable to highly attenuated regions such as fetal head and spine.
• HQ-Vision – Allows users get high resolution images to detect clinically important details.

New Samsung Exclusive Technologies

• MV-Flow – Offers a detailed view of blood flow in relation to the surrounding tissues or pathology with an enhanced spatial and temporal resolution.
• LumiFlow – Provides a three-dimensional visualization of continuous and volumic vascular image.

Seamless Workflow

• Wide Control Panel – Adopted rotatable control panel with a top-notch swivel mechanism. Allows moving range of 550mm from left to right and 219mm from top to bottom.
• Touch Customization – Allows users to easily change the position of the button on the touchscreen for each mode and feature.

In addition to HERA W10, Samsung is unveiling a prototype of HERA I10, which shares the same platform as HERA W10, but with a completely new ergonomic redesign. HERA I10 is a next-generation chair-type ultrasound system with a design that is entirely different from the industry norm that meets the unique needs of Ob/Gyn professionals. HERA I10 provides a comfortable experience for both the doctor and the patient by addressing the discomfort caused by the spacing and the position of the clinicians and eliminating the need for the patient to shift the body, as it automatically adjusts for proper positioning. It also reduces the force required to move the control panel back and forth and the resistance force on the wrist.

A new ultrasound solution SonoSync will also be introduced, which allows healthcare professionals to see real-time ultrasound scanning images in remote places¹. SonoSync provides two-way communications through voice chatting and marking, improving accessibility. It can be installed on various devices such as smartphones, laptops and desktop PCs, allowing multilocation real-time training and education among healthcare professionals. Its Multiview feature also increases productivity by viewing multiple image scans in one screen.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

¹SonoSync may not be used for diagnostic purposes at all times. Its availability may vary in different countries, according to regulatory approvals.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.